Literature DB >> 25850549

Intermediate-stage HCC--upfront resection can be feasible.

Jian-Hong Zhong1, Shi-Dong Lu1, Yan-Yan Wang1, Liang Ma1, Le-Qun Li1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25850549     DOI： 10.1038/nrclinonc.2014.122-c3

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  16 in total

1.  Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

Authors:  Jordi Bruix; Jean-Luc Raoul; Morris Sherman; Vincenzo Mazzaferro; Luigi Bolondi; Antonio Craxi; Peter R Galle; Armando Santoro; Michel Beaugrand; Angelo Sangiovanni; Camillo Porta; Guido Gerken; Jorge A Marrero; Andrea Nadel; Michael Shan; Marius Moscovici; Dimitris Voliotis; Josep M Llovet
Journal:  J Hepatol       Date:  2012-06-19       Impact factor: 25.083

2.  Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Fei-Xiang Wu; Hang Li
Journal:  Tumour Biol       Date:  2014-09-09

3.  Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.

Authors:  Katerina Malagari; Mary Pomoni; Hippocrates Moschouris; Evanthia Bouma; John Koskinas; Aspasia Stefaniotou; Athanasios Marinis; Alexios Kelekis; Efthymia Alexopoulou; Achilles Chatziioannou; Katerina Chatzimichael; Spyridon Dourakis; Nikolaos Kelekis; Spyros Rizos; Dimitrios Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2012-05-22       Impact factor: 2.740

Review 4.  Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.

Authors:  Roberto S Oliveri; Jørn Wetterslev; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

5.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

6.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

Review 7.  Treatment of intermediate-stage hepatocellular carcinoma.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675

8.  Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.

Authors:  Jian-hong Zhong; Yang Ke; Wen-feng Gong; Bang-de Xiang; Liang Ma; Xin-ping Ye; Tao Peng; Gui-sheng Xie; Le-qun Li
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

9.  Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension.

Authors:  Jian-Hong Zhong; Hang Li; Nan Xiao; Xin-Ping Ye; Yang Ke; Yan-Yan Wang; Liang Ma; Jie Chen; Xue-Mei You; Zhi-Yuan Zhang; Shi-Dong Lu; Le-Qun Li
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

10.  GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.

Authors:  R Lencioni; M Kudo; S-L Ye; J-P Bronowicki; X-P Chen; L Dagher; J Furuse; J F Geschwind; L Ladrón de Guevara; C Papandreou; T Takayama; S K Yoon; K Nakajima; R Lehr; S Heldner; A J Sanyal
Journal:  Int J Clin Pract       Date:  2013-11-28       Impact factor: 2.503
View more
  17 in total

1.  Hepatic Resection Improves Long-Term Survival of Patients with Large and/or Multinodular Hepatocellular Carcinoma.

Authors:  Ling Deng; Chun Yang; Le-Qun Li; Jian-Hong Zhong
Journal:  J Gastrointest Surg       Date:  2015-10-13       Impact factor: 3.452

2.  The STORM trial and beyond: narrowing the horizon of adjuvant sorafenib for postoperative hepatocellular carcinoma.

Authors:  Jian-Hong Zhong
Journal:  Tumour Biol       Date:  2015-11

3.  Intermediate-stage HCC--upfront resection can be feasible.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2015-04-07       Impact factor: 66.675

4.  Properly assessing CD133 as a risk factor for poor prognosis in patients with hepatocellular carcinoma after resection.

Authors:  Hao-Feng Lu; Wei-Ping Yuan; Mi Li; Qiang Huang; Jian-Ping Liu; Le-Qun Li; Jian-Hong Zhong
Journal:  Tumour Biol       Date:  2015-05-31

5.  Subclassification of patients with solitary hepatocellular carcinoma based on post-hepatectomy survival: a large retrospective study.

Authors:  Lei Liu; Qi-Shun Zhang; Ling-Hui Pan; Jian-Hong Zhong; Zhen-Ming Qin; Yan-Yan Wang; Hong-Gui Qin; Wen-Feng Gong; Lu-Nan Qi; Bang-De Xiang; Le-Qun Li
Journal:  Tumour Biol       Date:  2015-11-11

Review 6.  Controversies and evidence of hepatic resection for hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Guido Torzilli; Hao Xing; Chao Li; Jun Han; Lei Liang; Han Zhang; Shu-Yang Dai; Le-Qun Li; Feng Shen; Tian Yang
Journal:  BBA Clin       Date:  2016-10-11

7.  Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making.

Authors:  Yong-Fa Zhang; Jie Zhou; Wei Wei; Ru-Hai Zou; Min-Shan Chen; Wan Yee Lau; Ming Shi; Rong-Ping Guo
Journal:  Br J Cancer       Date:  2016-10-04       Impact factor: 7.640

8.  Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma.

Authors:  Shi-Dong Lu; Yan-Yan Wang; Ning-Fu Peng; Yu-Chong Peng; Jian-Hong Zhong; Hong-Gui Qin; Bang-De Xiang; Xue-Mei You; Liang Ma; Le-Qun Li
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

9.  Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma.

Authors:  Jian-Hong Zhong; Xue-Mei You; Shi-Dong Lu; Yan-Yan Wang; Bang-De Xiang; Liang Ma; Fei-Xiang Wu; Wei-Ping Yuan; Ying Chen; Le-Qun Li
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

10.  Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas >5 cm Without Extrahepatic Metastases: An Imaging-Based Retrospective Study.

Authors:  Meng Li; Yongjie Xin; Sirui Fu; Zaiyi Liu; Yong Li; Baoshan Hu; Shuting Chen; Changhong Liang; Ligong Lu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.